Related Experiment Video
Updated: Jul 16, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Driving mishaps and hypoglycaemia: risk and prevention
D Cox1, W Clarke, L Gonder-Frederick
1University of Virginia, Charlottesville, Virginia, USA.
International Journal of Clinical Practice. Supplement
|October 12, 2001
Summary
Patients with diabetes experiencing severe hypoglycemia, or low blood glucose, face increased driving accident risks. Awareness training is crucial for safe driving and preventing accidents related to hypoglycemia.
Area of Science:
- Endocrinology
- Neuroscience
- Traffic Safety
Background:
- Driving is a complex cognitive task vulnerable to impairment from severe hypoglycemia.
- Intensive insulin therapy increases hypoglycemia risk, yet its impact on driving skills is understudied.
- Type 1 diabetes patients exhibit higher driving accident rates compared to non-diabetic individuals and type 2 diabetes patients.
Purpose of the Study:
- To investigate the relationship between hypoglycemia and driving impairment in diabetic patients.
- To assess the impact of driving on blood glucose levels and identify safe driving thresholds.
- To evaluate the effectiveness of behavioral interventions in mitigating driving risks associated with hypoglycemia.
Main Methods:
- Survey analysis of driving accidents in diabetic patients.
- Driving simulation tests to evaluate performance at varying blood glucose levels.
- Quantification of neuroglycopenia using EEG alpha-theta differences.
Main Results:
- Driving performance deteriorates around 3.6 mmol/l blood glucose, often unrecognized by drivers.
- Hypoglycemic episodes while driving were linked to increased accident incidence and reduced self-monitoring.
- Self-treatment of hypoglycemia in drivers correlated with more recognized symptoms and less neuroglycopenia.
Conclusions:
- Recommend patients avoid driving with blood glucose below 4.5 mmol/l and cease driving if it drops below 4 mmol/l.
- Advise immediate roadside cessation, glucose monitoring, treatment, and a return to normal function before resuming driving.
- Behavioral interventions like Blood Glucose Awareness Training (BGAT) and Hypoglycaemia Anticipation, Awareness and Treatment Training (HAATT) significantly reduce driving mishaps.
Related Concept Videos
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...